different bacterial strains, CBS News reported.
A Food and Drug Administration spokesperson tells ABC News the agency is “aware” of Abbott’s new recall of Similac products from their Ohio plant, and say they “don’t expect” it to impact overall domestic supply.
According to the agency spokesperson, the FDA has relaxed their import discretion, allowing foreign formula makers to sell their products on the U.S. market. That is why they believe this latest recall from Abbott shouldn’t have the same kind of drastic impact as the massive one from earlier this year.
“Parents and caregivers have many additional formula options today thanks to FDA’s efforts and those of many of our government partners,” FDA’s spokesperson said, adding they are “more than doubling the number of formula manufacturers” making formula for U.S. infants.
Abbott advises customers to not use any recalled formula. Visit similacrecall.com to see a list of the lot numbers affected by the recall.